National Comprehensive Cancer Network

The Robert H. Lurie Comprehensive Cancer Center is dedicated to the process of discovery, advancing medical knowledge, and providing compassionate, state-of-the-art cancer care. Outstanding basic, translational, and clinical research complements a full range of prevention, early detection, treatment, rehabilitation, and palliative care programs for all types of cancer. Primary and tertiary programs on the main medical center campus treat nearly 10,000 new cancer cases annually and the Center additionally maintains affiliations with four teaching hospitals located throughout the metropolitan Chicago area. Across this system, more than 2,000 patients are annually accrued to approximately 220 clinical trials conducted by the Center.

· The Lurie Cancer Center has major research strengths in breast, genitourinary, gastrointestinal, aerodigestive, neurologic, and gynecologic cancers; hematologic malignancies; and pediatric oncology. Basic and translational research programs in hormone action/signal transduction, angiogenesis, biologic therapies, and nanotechnology are nationally and internationally recognized. Overall, the Center's 250 clinicians and scientists generate in excess of $150 million annually in extramural grant funding.

· A full range of medical, surgical, and radiation oncology treatment facilities is complemented by exceptional screening facilities and programs for breast, prostate, colon, and ovarian cancers; a comprehensive, multidisciplinary breast center; the region's leading genetic testing and counseling service; a model academic Hospice/Palliative Medicine Program that has achieved national prominence; and a novel, comprehensive program in liver-directed therapies that includes surgeons, medical oncologists, and interventional radiologists.

• Profile Overview
• Adult Oncology
• Genetic Testing
• Pediatric Oncology
• Find Clinical Trials